| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
Cancer Center, Burnham Institute for Medical Research, La Jolla, California
Requests for reprints: Kristiina Vuori, Cancer Center, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3129; Fax: 858-795-5272; E-mail: kvuori{at}burnham.org.
Neuroblastomas are extremely aggressive, although heterogeneous, cancers with a poor prognosis upon metastasis. Some evidence has suggested a correlative silencing of caspase-8 with MYCN amplification in neuroblastoma. A prognostic effect of this silencing, however, has been disputed. We report here hitherto undescribed roles for caspase-8 in the modulation of cell adhesion and subsequent activation of the Erk signaling pathway. Re-expression of caspase-8 in neuroblastoma cells lacking endogenous caspase-8 expression was found to promote cell adhesion to extracellular matrix and to activate adhesion-dependent signaling pathways, such as the Erk kinase cascade. This function of caspase-8 occurred irrespective of its proteolytic activity. Additionally, a pool of caspase-8 was shown to co-localize with the Src tyrosine kinase at the cellular periphery. Furthermore, our studies showed that caspase-8 forms a physical protein complex with Src via its death effector domains (DED) and maintains the complex in a detergent-soluble fraction. We also show that the DEDs of caspase-8 alone are necessary and sufficient to recreate the adhesive and biochemical phenotypes observed with the full-length protein, suggesting that caspase-8 may exert these effects via its association with Src. This protein complex association of caspase-8 and Src, and concomitant downstream signaling events, may help reconcile why a potential tumor suppressor such as caspase-8 is rarely absent in cancers. [Cancer Res 2007;67(24):11704–11]
This article has been cited by other articles:
![]() |
A. Jacquel, N. Benikhlef, J. Paggetti, N. Lalaoui, L. Guery, E. K. Dufour, M. Ciudad, C. Racoeur, O. Micheau, L. Delva, et al. Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages Blood, October 22, 2009; 114(17): 3633 - 3641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Finlay, A. Howes, and K. Vuori Critical Role for Caspase-8 in Epidermal Growth Factor Signaling Cancer Res., June 15, 2009; 69(12): 5023 - 5029. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Parsons, P. Patel, D. J. Brat, L. Colbert, and P. M. Vertino Silencing of TMS1/ASC Promotes Resistance to Anoikis in Breast Epithelial Cells Cancer Res., March 1, 2009; 69(5): 1706 - 1711. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Torres, A. Mielgo, D. Barila, D. H. Anderson, and D. Stupack Caspase 8 Promotes Peripheral Localization and Activation of Rab5 J. Biol. Chem., December 26, 2008; 283(52): 36280 - 36289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Frisch Caspase-8: Fly or Die Cancer Res., June 15, 2008; 68(12): 4491 - 4493. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |